
pmid: 38552610
pmc: PMC7616034
The integration of cancer biomarkers into oncology has revolutionized cancer treatment, yielding remarkable advancements in cancer therapeutics and the prognosis of cancer patients. The development of personalized medicine represents a turning point and a new paradigm in cancer management, as biomarkers enable oncologists to tailor treatments based on the unique molecular profile of each patient's tumor. In this review, we discuss the scientific milestones of cancer biomarkers and explore future possibilities to improve the management of patients with solid tumors. This progress is primarily attributed to the biological characterization of cancers, advancements in testing methodologies, elucidation of the immune microenvironment, and the ability to profile circulating tumor fractions. Integrating these insights promises to continually advance the precision oncology field, fostering better patient outcomes.
Medical Sciences, Bioinformatics, 610, Medical Oncology, Article, Biomedical Informatics, Signalling & Oncogenes, Ecology,Evolution & Ethology, Neoplasms, 616, Medical Specialties, Medicine and Health Sciences, Biomarkers, Tumor, Tumor Microenvironment, Humans, Precision Medicine, Computational & Systems Biology, Chemical Biology & High Throughput, Human Biology & Physiology, Tumor, Humans; Biomarkers, Tumor; Medical Oncology/methods; Neoplasms/therapy; Neoplasms/drug therapy; Precision Medicine/methods; Tumor Microenvironment, Genome Integrity & Repair, Tumour Biology, Oncology, Genetics & Genomics, Biomarkers
Medical Sciences, Bioinformatics, 610, Medical Oncology, Article, Biomedical Informatics, Signalling & Oncogenes, Ecology,Evolution & Ethology, Neoplasms, 616, Medical Specialties, Medicine and Health Sciences, Biomarkers, Tumor, Tumor Microenvironment, Humans, Precision Medicine, Computational & Systems Biology, Chemical Biology & High Throughput, Human Biology & Physiology, Tumor, Humans; Biomarkers, Tumor; Medical Oncology/methods; Neoplasms/therapy; Neoplasms/drug therapy; Precision Medicine/methods; Tumor Microenvironment, Genome Integrity & Repair, Tumour Biology, Oncology, Genetics & Genomics, Biomarkers
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 375 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 0.1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 0.01% |
